India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh
Unapproved drops for dry eyes pose risks: Govt
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Govt highlights multi-layer framework to curb misleading advertisements
Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal
Study finds rising resistance to a last-resort antibiotic in Africa
Patna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
Pharma Company Bus Overturns in Miyapur, 10 Employees Injured, Probe Underway
India regulator asks states to implement uniform drug licensing norms to end quality gapsSun Pharma acquires Japan’s Pola Pharma
New Delhi: Drug major Sun Pharma Thursday said it has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100…
Hetero Labs Limited acquires Tarbis Farma in Spain
Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that its European subsidiary Amarox Limited has acquired Tarbis Farma, S.L.U., a…
FSSAI to focus on enforcement of food standards in 2019
With new food quality standards in place, regulator FSSAI will focus on enforcing the regulations without impacting businesses, CEO Pawan Agarwal said Tuesday. During 2018, FSSAI accelerated the process of…
Controversies hurt Johnson & Johnson’s sales in India
Mumbai: US drug maker Johnson & Johnson, stung by controversies over its baby talc and medical devices, posted its first sales decline in India since at least 2002, according to…
Drug companies greet 2019 with U.S. price hikes
NEW YORK – Drugmakers kicked off 2019 with price increases in the United States on more than 250 prescription drugs, including the world’s top-selling medicine, Humira, although the pace of…
Online pharma sales to hit ₹25,000cr in 4 years
MUMBAI: The domestic epharmacy market is poised to touch Rs 25,000 crore by 2022, at a robust CAGR of 63%, buoyed by an increased access of medicines to a majority…
Cipla recalls 4,800 bottles of anti-HIV tablets from US
Drug major Cipla is recalling 4,800 bottles of Nevirapine extended release tablets used for the treatment of human immunodeficiency virus (HIV) from the American market, according to a report by…
Shilpa Medicare gets USFDA nod for cancer treatment injection
NEW DELHI: Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers. The company has…
Govt to give preference to domestically produced drugs for public procurement
New Delhi: The government Tuesday said preference for public procurement programmes in the pharma sector will be given to domestically produced drugs with minimum of 75 per cent local content…
Aurobindo Pharma USA recalls 80 lots of blood pressure drug from America
NEW DELHI: Aurobindo Pharma USA Inc is recalling 80 lots of tablets used for treatment of high blood pressure and heart failure from the American market due to presence of…